Clinical trial Recruiting at 1 site Interventional Ages 18 to 39

Understanding how a ketogenic diet affects cholesterol levels

Official title: Mechanism of Ketogenic Diet-Induced Hypercholesterolemia

Run by Washington University School of Medicine · NCT06894004 · Data updated 2026-11-12

This study is testing how a very-low carbohydrate ketogenic diet affects cholesterol levels in normal-weight adults who might be more likely to have high cholesterol on this diet.

Quick facts

Study typeInterventional
Ages18 Years to 39 Years
SexAll
Enrollment100 (estimated)
SponsorWashington University School of Medicine
Academic / other
Locations1 site (St Louis, Missouri)
StatusRecruiting
StartedFebruary 24, 2025
Main results expectedNovember 30, 2030
Study endsNovember 30, 2030
Registry record updatedMarch 23, 2026
Trial IDNCT06894004 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are normal-weight adults aged 18 to 40 who are at low cardiovascular risk and do not have a history of familial hypercholesterolemia.

Probably not a fit

Patients with a personal or family history of familial hypercholesterolemia or those currently using lipid-lowering medications may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates how a very-low carbohydrate ketogenic diet can lead to increased cholesterol levels in normal-weight adults. It will first screen participants to identify those who are susceptible to developing high cholesterol on this diet. Eligible participants will undergo a randomized crossover study involving two different dietary interventions: a ketogenic diet and a control diet, with measurements of lipoprotein and cholesterol kinetics taken during the study. The goal is to clarify the mechanisms behind diet-induced hypercholesterolemia in susceptible individuals.

Why it matters

Potential benefit: If successful, this study could provide insights into dietary impacts on cholesterol levels, potentially guiding dietary recommendations for individuals at risk of hypercholesterolemia.

How similar studies have gone: While the effects of ketogenic diets on cholesterol are known, this specific investigation into the mechanisms of diet-induced hypercholesterolemia in normal-weight individuals is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. age ≥ 18 and \< 40 years
2. BMI ≥ 18.5 and \< 25.0 kg/m2
3. baseline serum LDL-c \< 150 mg/dL (\< 3.9 mmol/L)
4. baseline serum TG \< 100 mg/dL (\< 1.1 mmol/L)
5. HbA1c ≤ 5.6%.

Exclusion Criteria:

1. personal or family history of familial hypercholesterolemia
2. current use of lipid-lowering drugs
3. currently on a ketogenic diet and unwilling to change diet
4. current tobacco use
5. hypertension
6. prediabetes or diabetes
7. elevated Lp(a) \> 6.5% of ApoB-containing lipoproteins at baseline
8. oral contraceptive use
9. contraindication to heparin
10. known atherosclerotic cardiovascular disease
11. unwilling to abstain from alcohol

Where it's running

  • Washington University School of Medicine
    St Louis, Missouri, United States
    Recruiting

Study contacts

  • Principal investigator: Max C Petersen, M.D., Ph.D. — Washington University School of Medicine
  • Study coordinator: Frannie Wilkinson, M.A.
  • Email: francesw@wustl.edu
  • Phone: (314) 362-0590

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.